Business · 04/02/2022
FDA Releases Revised Draft Guidance on Assessing Blood Pressure Effects of Drugs
The Food and Drug Administration (FDA) has made a revised draft guidance available for industry, focusing on the premarketing assessment of a drug's impact on blood pressure, a critical factor in stroke, heart attack, and death risk
Original source language: Federal Register — Food and Drug AdministrationOpen original release →